Xiaobin Xu, PhD, MBA, is an experienced investment analyst specializing in biotech, pharmaceutical, healthcare, and medtech sectors. Currently an Associate Director at Regeneron, they have over eight years of experience in drug development, regulatory submissions, and team leadership. Xiaobin previously served as a Senior Principal Scientist at Regeneron, leading a team to advance multiple drugs to market, while authoring numerous papers and patents. They hold an MBA with Dean's Honors from Columbia Business School and are pursuing both a Master's and a PhD in Chemistry at Boston University and Sichuan University, respectively.
This person is not in the org chart
This person is not in any teams
This person is not in any offices